Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)
China flag China · Delayed Price · Currency is CNY
107.92
+5.90 (5.78%)
Feb 3, 2026, 3:04 PM CST

SHE:300436 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Cash & Equivalents
245.21143.95202.83238.98393.57135.99
Cash & Short-Term Investments
245.21143.95202.83238.98393.57135.99
Cash Growth
92.55%-29.03%-15.13%-39.28%189.41%45.10%
Accounts Receivable
87.0770.4369.7647.9754.2650.66
Other Receivables
1.428.83258.214.942.02
Receivables
88.4799.2694.7656.1859.252.68
Inventory
143.24114.48111.4868.6681.852.71
Prepaid Expenses
-----0.01
Other Current Assets
76.2649.6140.2230.4815.3216.15
Total Current Assets
553.17407.3449.29394.3549.89257.54
Property, Plant & Equipment
550.81588.4639.49584.83509.63420.78
Long-Term Investments
77.7580.18108.81170.7499.9869.93
Goodwill
58.9758.9758.9758.9758.9758.97
Other Intangible Assets
225.47251.66292.08100.83118.9392.15
Long-Term Deferred Tax Assets
1.381.471.1571.0743.0723.9
Long-Term Deferred Charges
40.9642.7847.7555.2232.5663.96
Other Long-Term Assets
11.368.0616.9458.8733.7418.55
Total Assets
1,5201,4391,6141,4951,4471,006
Accounts Payable
208.3453.3849.2922.2785.5379.45
Accrued Expenses
11.62174.67175.3489.0538.6237.76
Short-Term Debt
144.13182.18219.18209.2777.76129.18
Current Portion of Long-Term Debt
111.12117.9272.1217.9462.47-
Current Portion of Leases
-0.10.180.190.11-
Current Income Taxes Payable
10.82.911.673.83.773.01
Current Unearned Revenue
5.983.5711.918.226.633.86
Other Current Liabilities
42.6740.0568.0757.827.4240.86
Total Current Liabilities
534.67574.78597.76408.55302.31294.12
Long-Term Debt
180.3142.36167.6984.044782
Long-Term Leases
--0.090.1--
Long-Term Unearned Revenue
62.1365.9939.9942.3345.5645.25
Long-Term Deferred Tax Liabilities
2.52.672.382.422.052.42
Other Long-Term Liabilities
271.78256.24237.311.79--
Total Liabilities
1,0511,0421,045539.22396.92423.79
Common Stock
159.27159.27159.27159.27158.78140
Additional Paid-In Capital
742.37607.93607.93671.32659.29176.43
Retained Earnings
-518.6-407.01-250.7197.88225.28260.17
Total Common Equity
383.04360.18516.48928.461,043576.6
Minority Interest
85.4436.652.7627.166.495.39
Shareholders' Equity
468.48396.78569.24955.621,050581.99
Total Liabilities & Equity
1,5201,4391,6141,4951,4471,006
Total Debt
435.56442.56459.27311.55187.33211.18
Net Cash (Debt)
-190.35-298.6-256.44-72.57206.24-75.19
Net Cash Per Share
-1.20-1.87-1.61-0.461.38-0.54
Filing Date Shares Outstanding
159.27159.27159.27159.27158.78140
Total Common Shares Outstanding
159.27159.27159.27159.27158.78140
Working Capital
18.5-167.48-148.48-14.25247.58-36.58
Book Value Per Share
2.402.263.245.836.574.12
Tangible Book Value
98.649.56165.44768.66865.45425.48
Tangible Book Value Per Share
0.620.311.044.835.453.04
Buildings
-565.95565.02536.94397.03393.34
Machinery
-267.27268.43179.92116.23108.6
Construction In Progress
-29.7629.8650.6147.2244.15
Source: S&P Global Market Intelligence. Standard template. Financial Sources.